A new era for cancer care in New Zealanders has dawned, as the first Accuray CyberKnife is set to dramatically reduce the treatment time and impacts of radiation therapy on patients.

Following many years of partnership and preparation with alphaXRT, Auckland Radiation Oncology (ARO) proudly introduced the country’s first CyberKnife in late 2022 and hopes to work with Health NZ to extend the reach of CyberKnife and support all New Zealand patients who could benefit from access to this tool.

ARO Clinical Director Dr Benji Benjamin says “We are committed to providing patients with options and access to the best treatment pathways possible in their fight against cancer. We are proud to lead New Zealand into a new era of radiation treatment and to be unlocking new tools for the benefit of as many patients as possible.”